Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-039326
Filing Date
2023-02-14
Accepted
2023-02-14 17:01:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d461700dsc13ga.htm SC 13G/A 41152
  Complete submission text file 0001193125-23-039326.txt   42686
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92710 | Film No.: 23631192
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GINKGO BIOWORKS, INC. 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address
Knight Thomas F. Jr. (Filed by) CIK: 0001885249 (see all company filings)

Type: SC 13G/A